Overview

Intranasal Insulin for COVID-19-related Smell Loss

Status:
Completed
Trial end date:
2021-12-20
Target enrollment:
Participant gender:
Summary
The aim of this study was to quantify the improvement in olfaction of 27 post-COVID-19 patients, after three intreventions of intranasal insulin during a four week period, with the help of the Threshold, Discrimination and Identification (TDI) score evaluated with Sniffin SticksĀ®.
Phase:
Phase 3
Details
Lead Sponsor:
Universidad Panamericana
Treatments:
Insulin
Insulin, Globin Zinc